oh my.. really?
It's a charitable organization. A bit a of your statement is correct- this piece-
this is awesome!
Technosphere in action!
KEY from the Mintaka foundation:
PREVENTION OF MATERNAL DEATH IN CHILDBIRTH
Of the approximately half a million women who die annually from causes related to pregnancy and childbirth, about 99% live in developing countries. For instance, in Niger, on average one girl in seven who survives to grow up will, later in life, die from such causes. The corresponding figure in the developed world is one in 7,300.
At least a quarter of these maternal deaths are a result of uncontrolled bleeding after giving birth.
Many deaths by bleeding could be prevented by an immediate intravenous injection of the drug oxytocin. However, oxytocin is unstable in warm climates and trained staff are not always available to give injections. With MannKind Corporation (USA), we have formulated oxytocin in a dry, stabilized form which can be loaded into a robust, very inexpensive, disposable inhaler, eliminating at the same time the need for injection. Administration by inhalation at last makes treatment possible outside centres with trained medical staff.
Some 98% of our formulation of oxytocin survives 8 months at 40°C, and the inhaler has proved a highly efficient means of delivery. The next step is to design and then execute a clinical safety trial in a developed county (medicines should not be safety-tested on fragile populations). If our expectation that there will be no safety issues proves justified, the way will then be open to forming a product development partnership to take the product to market.
A substantial decrease in the ~140,000 deaths per year and in the number of women (currently 1,600,000) who survive, but in a seriously weakened state. The return to their families of women in good health, ready to care for their children and assume once again their responsibilities in their community.
yes.. we will remember!
Yes I will remember when our friend, dear AL, gave us a life changing product that can help several million people battle a disease that can be devastating and extremely intrusive if it is not constantly being checked and monitored. He sealed his LEGACY as an inventor, the finest of engineers and did not care that the "establishment" scorned and scoffed at him and his tiny little company. He beat the odds and introduced a product that the mightiest of drug companies (Pfizer) could not market. He used most of his own money to do this!
dear Colten-- When faced with giants like Al Mann, one can only humble themselves to them, NEVER ever under estimate their conviction!!!!
I HOPE we can keep this at the top until 2017!
I want to see $37 LMAO!!
0. MOST IMPORTANT- DIABETICS LOVE IT!!
1. Matt - upped his game
2. Al-- ever present;ever gracious -Lifetime award -with Sanofi on one side, Medatronic on the other
3. Hakan- Flew to Paris to tell Sanofi- Lets go!
4. Triple production
5. Jeffries -PT $37 in 2017
6. Griffin - PT 16.25
7. GS- downgrade to $2 -BUY signal
8. Krap - Sold half his PUTs- Another BUY SIGNAL
9. BOA - Call purchases
10- Martin what's his name - IDwhateverOIT!
11. -FDA -Competition oral drugs cause ketoacidosis
12 ARAB TV
13. No Dilution for BOA notes- Borrow from AL.- (Al ends up owning more of the company)
14 Any--- questions?????!!!!!!
Hey shortie, guess what ??!! I can wait until 2017. Can you?